Biobeat Platform, BB-613WP Patch
K-Number: K212153 · 2022-03-25
Device Summary
Frequently Asked Questions
What is the Biobeat Platform, BB-613WP Patch?
Biobeat Platform, BB-613WP Patch is a medical device that received FDA 510(k) clearance on 2022-03-25. The listed applicant is Biobeat Technologies , Ltd.. The 510(k) number is K212153.
When did Biobeat Platform, BB-613WP Patch receive FDA 510(k) clearance?
Biobeat Platform, BB-613WP Patch received FDA 510(k) clearance on 2022-03-25, under 510(k) number K212153.
Who is the listed applicant for Biobeat Platform, BB-613WP Patch?
The FDA 510(k) record lists Biobeat Technologies , Ltd. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Biobeat Platform, BB-613WP Patch?
The FDA product code for Biobeat Platform, BB-613WP Patch is DQA.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Biobeat Technologies , Ltd. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: DQA)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.